Ines Monte
Ines Monte is an expert in Cardiology at University of Catania (Italy). Ines Monte has authored 134 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 304 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Genetics - Biochemistry - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 134
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program. PMID 41519390 — cardiology, cardiomyopathy, hypertrophic, therapeutics, cardiomyopathies | Int J Cardiol | 2026 | 0 |
| Diagnostic Predictive Scores of Amyloid Cardiomyopathy in Patients with Heart Failure with Preserved Ejection Fraction and Left Ventricular Hypertrophy. PMID 41295343 — hypertrophy, left ventricular, heart failure, probability, heart, heart failure, diastolic, hypertrophy, amyloidosis, cardiomyopathy, restrictive, therapeutics, amyloid, cardiomyopathies | J Cardiovasc Dev Dis | 2025 | 0 |
| Exercise Stress Echo for the Evaluation of the Outcomes of Minimally Invasive Mitral Valve Repair: A 2-year Follow-up Pilot Study. PMID 41114064 — exercise, pilot projects, pilots, echocardiography, stress, mitral valve, stress, physiological, echocardiography, therapeutics, mitral valve insufficiency, hemodynamics | J Cardiovasc Echogr | 2025 | 0 |
| Cardiac Phenotypes in Fabry Disease: Genetic Variability and Clinical Severity Staging Correlation in a Reference Center Cohort. PMID 41010031 — genomics, rare diseases, heart failure, phenotype, genotype, therapeutics, mutation, prognosis, fabry disease | Genes (Basel) | 2025 | 0 |
| Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis. PMID 40609138 — heart failure, disease progression, prealbumin, prognosis, cardiomyopathies | JACC Heart Fail | 2025 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map